Cancer Equity Colloquium 2023

Cambridge, MA US
April 21, 2023 to April 22, 2023

 

 

This is a hybrid event


Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequities. The goal of the Colloquium is to bring together individuals from healthcare, academia, private/public business sector, and the public at large to develop unique approaches to tackling these inequities. We know that impactful initiatives to promote cancer equity require the skills and experiences of individuals from all these sectors of society. The speakers will reflect a similar mixture of backgrounds. Attendees will have the opportunity to engage with each other and the Cancer Equity Colloquium faculty in hopes to develop novel partnerships.

Target Audience

This activity is intended for Physicians, Nurses, Pharmacists, Psychologists, Physician Assistants, Social Workers, Other members of the healthcare team, General Public, and Patients & Caregivers.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Recognize and understand existing inequities in cancer care.
  2. Discuss solutions amongst the treatment team to address factors leading to cancer inequity.
  3. Develop collaborative initiatives to promote equity in cancer care.

ACCOMMODATIONS:

A limited number of rooms have been reserved at the Boston Marriott Cambridge for the nights of April 20 and 21 at nightly rate of $199. Hotel room rates are subject to applicable state and local taxes (currently 14.45% and a 1.5% tourism fee) in effect at the time of check-out. To book your room, you may call Marriott reservations at 1 (800) 228-9290 or (617) 494-6600 and mention the “MGH Cancer Equity Colloquium” room block or CLICK HERE to reserve online. The reservation deadline is Thursday, March 30, 2023.


For exhibit space, please contact ebrooks3@mgh.harvard.edu


 

Additional Information

Provided by: 

Massachusetts General Hospital Cancer Center & Mass General Brigham 

Course summary
Available credit: 
  • 13.50 AMA PRA Category 1 Credit™
  • 13.50 Nursing Contact Hours
  • 13.50 Participation
Course opens: 
12/05/2022
Course expires: 
06/09/2023
Event starts: 
04/21/2023 - 8:00am EDT
Event ends: 
04/22/2023 - 5:00pm EDT
Cost:
$100.00

Friday, April 21, 2023 | 7:15am - 5:30pm

7:15amRegistration and Breakfast*
8:00Introduction | Colin D. Weekes, MD, PhD & Brenda Lormil, MSN, FNP-C
8:10Keynote Address: Improving Cancer Equity through Precision Medicine | Karen Winkfield, MD, PhD
8:55Sustained Mentorship: An Integral Component to Achieve Cancer Equity | Charles Thomas, MD
9:25Diversity, Inclusion and Equity as Collective Competitive Advantage | Clifton David Fuller, MD, PhD
10:10BREAK*
10:25Importance of Early Mentorship for Minorities Pursuing Medicine | Kenley Preval
10:45Mentorship: Supporting the Growth of the Next Generation | 
Moderator: Charles Thomas, MD
Panelists: Cesar Castro, MD; Kenley Preval; Clifton David Fuller, MD, PhD
11:45amLUNCH*
12:45pmProstate Cancer Community Engagement and the Male Patient | Jean Claude Noel, MS, MA
1:05The Compounding Effects of Cancer: "My Voice, My Story, My Truth"
Moderator: Brenda Lormil, MSN, FNP-C
Panelists: Crystal Davis, RN; Mike Moise, MSA, CPA; Stanley Rameau; Taneshia Camillo-Sheffey
2:05Improved Survival in Cancer but Continued Disparities: Planning the Future with Precision Medicine, but Assessing the Past through the Rear View Mirror | Edith Mitchell, MD
2:35BREAK*
2:50How Can I Help You? Navigating Barriers to Care | 
Moderator: Brenda Lormil, MSN, FNP-C
Panelists: ​​​​Michelle Barber, MS, GNP-BC, AOCNP; S. Autumn Gaston, BSN, RN; Nora Hathaway, NP; Natasha Gross Jean, RN, BSN, OCN
3:50Democratization of Technology | Cesar Castro, MD
4:35Overcoming Barriers to Representative Clinical Trial Enrollment | Jamie L. Studts, PhD
5:20Closing Remarks
5:30pmAdjourn

7:00pm – Welcome Reception @ Artists for Humanity (100 West 2nd Street, Boston, MA 02127)
                 Complimentary transportation will be provided from meeting venue
 

*The exhibit hall will be open during breakfast, breaks, and lunch

 

Saturday, April 22, 2023 | 7:15am - 4:00pm

7:15amBreakfast*
8:00Welcome | Colin D. Weekes, MD, PhD & Brenda Lormil, MSN, FNP-C
8:05The Role of Cancer Centers in Community Engagement | 
Moderator: Colin D. Weekes, MD, PhD
Panelists: A. William Blackstock Jr., MD; Ruben A. Mesa, MD, FACP; Robert A. Winn, MD
9:05Faith-Based Leadership, Support, and Advocacy Panel | 
Moderator: Karen Burns White
Panelists: Cesar Depaz; Rev. Deborah Hamilton, MDiv, BSN, RN, FCN; Rev. Jean J.M. Louis; Rev. Gloria E. White-Hammond, MD, MDiv
10:05BREAK*
10:20Inequities in Cancer Health Outcomes: Can Strategies Leveraging Noncoding RNA Biology Helps? | Olorunseun (Seun) Ogunwobi, MD, PhD
11:05Pharmaceutical Industry Initiatives to Approach Cancer Inequity |
Panelists: Neelima Denduluri, MD, FASCO, Lisa Lewis, MPH; Megan McKenzie, MA; Patrecia Valone, MS
12:05pm LUNCH*
12:50Using Healthcare Delivery Systems to Improve Cancer Health Equity | Christopher Lathan, MD, MS, MPH
1:35Community-Based Research to Understanding Lung Cancer | Raymond Osarogiagbon, MD, FACP
2:20Cancer Equity Programs in Rural America | Electra A. Paskett, PhD
3:05BREAK*
3:20Fireside Chat | Karen Winkfield, MD, PhD & Colin Weekes, MD, PhD
4:05pmAdjourn


*The exhibit hall will be open during breakfast, breaks, and lunch

Boston Marriott Cambridge
50 Broadway
Cambridge, MA 02142
United States

ACCOMMODATIONS:

A limited number of rooms have been reserved at the Boston Marriott Cambridge for the nights of April 20 and 21 at nightly rate of $199. Hotel room rates are subject to applicable state and local taxes (currently 14.45% and a 1.5% tourism fee) in effect at the time of check-out. To book your room, you may call Marriott reservations at 1 (800) 228-9290 or (617) 494-6600 and mention the “MGH Cancer Equity Colloquium” room block or CLICK HERE to reserve online. The reservation deadline is Thursday, March 30, 2023.

Course Co-Directors

Colin D. Weekes, MD, PhD
Christopher D. Horner Endowed Chair in Pancreatic Cancer,
Director, Pancreatic Cancer Research,
Director, Cancer Center Grand Rounds,
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Brenda Lormil, MSN, FNP-C
Nurse Practitioner, Massachusetts General Hospital Cancer Center;
Founder, Haitian American Medical Association (HAMA)
 

Speakers

Michele Barber, MS, GNP-BC, AOCNP
Associate Director, Oncology Patient Engagement, Alkermes;
Director-at-large, Boston Oncology Nursing Society (BONS)

A. William Blackstock Jr., MD
Chair, Radiation Oncology,
Interim Director, Comprehensive Cancer Center,
Atrium Health Wake Forest Baptist          

Karen Burns White
Deputy Associate Director, Initiative to Eliminate Cancer Disparities,
Dana-Farber / Harvard Cancer Center

Cesar Castro, MD
Program Director, Gynecologic Oncology
Massachusetts General Hospital Cancer Center

Taneshia Camillo-Sheffey
Consultant, Founder & Director,
The Haute House Design Studio
MadelNcubator, Inc

Crystal Davis, RN
Registered Nurse,
Beth Israel Deaconess Medical Center

Neelima Denduluri, MD, FASCO
Global Clinical Head, Late Phase Research & Development,
AstraZeneca

Cesar Depaz
Senior Pastor, Hispanic Community Church of Boston

Clifton David Fuller, MD, PhD
Professor, Division of Radiation Oncology,
The University of Texas MD Anderson Cancer Center

S. Autumn Gaston, BSN, RN
Infusion Nurse, Termeer Center,
Massachusetts General Hospital Cancer Center

Rev. Deborah Hamilton, MDiv, BSN, RN, FCN
Lecturer, Dept. of Health Sciences (part-time), Northeastern University;
Staff Chaplain, Boston Medical Center (part-time)

Nora Hathaway, NP
Inpatient Medical Oncology,
Massachusetts General Hospital Cancer Center

Natasha Gross Jean, RN, BSN, OCN
Hematology Clinic Infusion Center,
Boston Medical Center

Christopher Lathan, MD, MS, MPH
Chief Clinical Access and Equity Officer, Dana-Farber Cancer Institute;
Christopher and Constance Hadley Family Chair at Dana Farber;
Associate Chief Medical Officer, Director, Dana-Farber Cancer Institute Network;
Associate Professor of Medicine, Harvard Medical School

Lisa Lewis, MPH
Director, Diversity, Equity and Inclusion in Clinical Trials,
Janssen Oncology

Rev. Jean J.M. Louis
Senior Pastor, Free Pentecostal Church of God

Meghan McKenzie, MA
Principal, Patient Inclusion & Health Equity,
Chief Diversity Office, Genentech

Ruben A. Mesa, MD, FACP
Senior Vice President, Atrium Health;
President, Cancer Service Line, Atrium Health;
Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center;
Vice Dean for Cancer Programs, Wake Forest School of Medicine

Edith P. Mitchell, MD, MACP, FCPP, FRCP (London)
Clinical Professor of Medicine and Medical Oncology,
Department of Medical Oncology,
Enterprise Vice President for Cancer Disparities,
Director, Center to Eliminate Cancer Disparities,
Associate Director, Diversity Affairs
Sidney Kimmel Cancer Center at Jefferson

Mike Moise, MSA, CPA
Director of Finances, Haitian America Medical Association;
Associate Director, Life Sciences Practice, CrossCountry Consulting

Jean Claude Noel, MS, MA
Atrium Consulting LLC - New York
Kets de Vries Institute - London
European Foundation for Management Development - Brussels
Mount Sinai Hospital Tisch Cancer Institute - New York
Boston Graduate School of Psychoanalysis - Boston

Olorunseun (Seun) Ogunwobi, MD, PhD
Director, Hunter College Center for Cancer Health Disparities Research (CCHDR);
Professor of Biological Sciences, Hunter College of The City University of New York

Raymond Osarogiagbon, MD, FACP
Chief Scientist,
Baptist Memorial Health Care Corporation;
Director, Multidisciplinary Thoracic Oncology Program,
Baptist Cancer Center

Electra D. Paskett, PhD
Marion N. Rowley Professor of Cancer Research,
Director, Division of Cancer Prevention and Control, College of Medicine;
Professor, Division of Epidemiology, College of Public Health;
Associate Director for Population Sciences and Community Outreach,
Comprehensive Cancer Center
The Ohio State University

Founding Director, Center for Cancer Health Equity, James Cancer Hospital

Kenley Preval
MD/PhD Student, UMass Medical School

Stanley Rameau
Founder & CEO, Renavest;
Founder & CEO, Paul Rameau

Jamie L. Studts, PhD
Professor, Division of Medical Oncology,
Scientific Director, Behavioral Oncology,
University of Colorado School of Medicine;
Program Co-Leader, Cancer Prevention and Control,
Co-Director, Population Health Shared Resource,
Member, Thoracic Oncology Research Initiative,
University of Colorado Cancer Center

Charles Thomas, MD
Professor and Chief of Radiation Oncology,
Dartmouth-Hitchcock Norris Cotton Cancer Center;
Deputy Editor, JAMA Oncology 

Patrecia Valone, MS
Global Head of Clinical Operations, Translational Clinical Oncology,
Novartis Institutes for BioMedical Research (NIBR)

Rev. Gloria E. White-Hammond, MD, MDiv
Co-Pastor, Bethel A.M.E. Church, Boston, MA;
Swartz Resident Practitioner in Ministry Studies,
Harvard Divinity School

Karen Winkfield, MD, PhD
Executive Director, Meharry Vanderbilt Alliance;
Ingram Professor of Cancer Research,
Professor of Radiology Oncology, VUMC;
Professor of Medicine, Meharry Medical College

Robert A. Winn, MD
Director and Lipman Chair in Oncology, VCU Massey Cancer Center;
Senior Associate Dean for Cancer Innovation,
Professor of Pulmonary Disease and Critical Care Medicine,
VCU School of Medicine

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Nursing
Mass General Brigham designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

 

Available Credit

  • 13.50 AMA PRA Category 1 Credit™
  • 13.50 Nursing Contact Hours
  • 13.50 Participation

Price

Cost:
$100.00
Please login or register to take this course.

NON-HEALTHCARE PROFESSSIONALS

CLICK HERE for free registration 
 

Professionals from healthcare and related industries must pay the registration fee to receive continuing education (CE) credit.
 

Cancellation Policy:
Registrations cancelled on or before April 7, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after April 7, 2023 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.


ACCOMMODATIONS:

A limited number of rooms have been reserved at the Boston Marriott Cambridge for the nights of April 20 and 21 at nightly rate of $199. Hotel room rates are subject to applicable state and local taxes (currently 14.45% and a 1.5% tourism fee) in effect at the time of check-out. To book your room, you may call Marriott reservations at 1 (800) 228-9290 or (617) 494-6600 and mention the “MGH Cancer Equity Colloquium” room block or CLICK HERE to reserve online. The reservation deadline is Thursday, March 30, 2023.